Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Alumni
  • Login
  • Volunteer
  • Clubs
  • Reunions
  • Bulletin
  • Class Notes
  • Help
  • Give Now
  • Stories
  • Alumni Directory
  • Lifelong Learning
  • Careers
  • Programs & Events
  • Giving
  • …→
  • Harvard Business School→
  • Alumni→
  • Stories→

Stories

Stories

16 Sep 2016

Gaining Ground on ALS

Re: Rob Blum (MBA 1991)
Topics: Health-Health Testing and TrialsScience-Science-Based BusinessSociety-Social Issues
ShareBar

If you are one of the 17 million people who participated in the ALS Ice Bucket Challenge, the money you raised may be helping to fund a first-of-its kind clinical collaboration between a nonprofit patient/disease advocacy organization and a biopharmaceutical company.

Robert Blum (MBA 1991) is president and CEO of Cytokinetics, Inc., a California-based company that focuses on biology-driven treatments for amyotrophic lateral sclerosis (ALS) and other debilitating diseases associated with muscle weakness. In 2015, the ALS Association awarded Cytokinetics a grant from funds raised during the Ice Bucket Challenge to support the Phase 3 trial of a promising investigational drug that is designed to slow the loss of lung function and muscle strength in patients with ALS.

“Clinical trials cost tens to hundreds of millions of dollars,” notes Blum, who started the California-based company in 1998. “But this grant is significant because it facilitates the sharing of plasma samples, collected from test subjects over time, with academic researchers.” The collaboration is a first for an international, late-stage trial and could help identify biomarkers for the disease’s causes and progression.

“The patients and caregivers we work with inspire us every day,” says Blum. “Bringing forward the first new medicine for ALS in nearly 25 years is a personal and professional crusade for everyone in our company.”

(Published September 2016)

Support the next generation of leaders Make a gift now
ShareBar

Featured Alumni

Rob Blum
MBA 1991

Post a Comment

Featured Alumni

Rob Blum
MBA 1991

Related Stories

    • 22 Feb 2022
    • HBS Alumni Bulletin

    Elevator Pitch: Good Vibrations

    Re: Laura Yecies (MBA 1988)
    • 16 Nov 2020
    • Washington Post; CNN; HBS Alumni Bulletin

    Moderna Announces Promising Vaccine Trial Results

    Re: Stefan Bancel (MBA 2000)
    • 24 Sep 2020
    • HBS Alumni Bulletin

    The Race for a Vaccine

    Re: Stefan Bancel (MBA 2000); Kate Bingham (MBA 1991); Gary P. Pisano (Harry E. Figgie, Jr. Professor of Business Administration Senior Associate Dean for Faculty Promotions and Tenure); By: April White
    • 23 Aug 2020
    • Daily Mail

    In the UK, She Leads the Search for a COVID Vaccine

    Re: Kate Bingham (MBA 1991)

More Related Stories

Stories Featuring Rob Blum

    • 13 Oct 2016
    • HBS Alumni News

    Adding Muscle to the Fight Against Disease

    Re: Rob Blum (MBA 1991); By: Deborah Blagg
 
 
 
 
  • Explore
  • Explore
  • Explore
  • Explore
  • Explore
  • Explore
  • Explore
  • Explore
  • Explore
ǁ
Campus Map
External Relations
Harvard Business School
Teele Hall
Soldiers Field
Boston, MA 02163
Phone: 1.617.495.6890
Email: alumni+hbs.edu
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
  • Terms of Use
Copyright © President & Fellows of Harvard College